{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Gly",
          "alt": "Arg",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 Gly2385Arg"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study links LRRK2 mutations to familial PD, with the Gly2385Arg variant altering the WD40 domain's net charge and potentially affecting protein function.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly connects LRRK2 mutations to PD pathogenesis and describes the Gly2385Arg variant as a missense change that modifies the WD40 domain's charge, which is relevant to PD mechanisms."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses transfection experiments to assess protein localization and toxicity under oxidative stress, which are standard functional assays for kinase domain variants.",
          "judgment": "Yes",
          "reasoning": "The assays (protein localization, toxicity, apoptosis) are consistent with functional studies of LRRK2 variants in PD research.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes wild-type and Gly2385Arg variant proteins as controls, and the experiments were performed in a large case-control sample (n=989) with statistical adjustments for age and gender.",
          "judgment": "Yes",
          "reasoning": "Both wild-type and variant controls were tested, and the study included multiple replicates (case-control sample size, statistical adjustments).",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The variant shows a statistically significant odds ratio (2.67, p=0.002) and population attributable risk, with a 95% confidence interval.",
          "judgment": "Yes",
          "reasoning": "The statistical analysis provides quantitative evidence of the variant's association with PD risk.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "The odds ratio (2.67) exceeds the threshold for supporting evidence (OddsPath > 2.0).",
          "judgment": "Yes",
          "reasoning": "The odds ratio of 2.67 falls within the 'supporting' category for pathogenic evidence (OddsPath > 2.0)."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    }
  ]
}